Last reviewed · How we verify

NCT03562260

Bipolar Surgical Release in Congenital Muscular Torticollis

Status unknown NA Last updated 2 July 2018
What this trial tests

NA trial testing bipolar release in Congenital Muscular Torticollis in 20 participants. Status unknown.

Timeline
10 August 2018
Primary endpoint
9 August 2019
9 August 2019

Quick facts

Lead sponsorMahidol University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date10 August 2018
Primary completion9 August 2019
Estimated completion9 August 2019
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Mahidol University

Who can join

Adults 5 to 15, any sex, with Congenital Muscular Torticollis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The congenital muscular torticollis is common disease in children.The indication for surgery is the children have persist deformity after 1 year old.Many surgical treatment had proposed such as unipolar release and bipolar release.By author experience the bipolar release had better results from complete cut the muscle both origin and insertion.This study wants to study the results of treatment in term of recurrence of the deformity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Congenital Muscular Torticollis

Currently open trials in the same condition.

Other Mahidol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03562260.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing